Alzheimer's disease

AC Immune's Janssen-partnered Alzheimer's vaccine spurs tau-attacking antibodies in early-stage trial
Fierce Biotech
Tue, 02/15/22 - 10:32 am
AC Immune
Janssen
JNJ
vaccines
Alzheimer's disease
clinical trials
Eli Lilly and Roche ask CMS not to be lumped in with Aduhelm’s restrictive judgment
Endpoints
Mon, 02/14/22 - 11:06 am
Eli Lilly
Roche
Biogen
Alzheimer's disease
Aduhelm
CMS
Denali Receives Formal Letter Regarding FDA Hold On Alzheimer's Potential Program
Benzinga
Mon, 02/14/22 - 11:00 am
Denali Therapeutics
FDA
DNL919
clinical hold
Alzheimer's disease
Cassava scores a win as FDA declines to intervene in petition to stop its Alzheimer's drug trials
Fierce Biotech
Fri, 02/11/22 - 11:41 am
Cassava Sciences
FDA
clinical trials
Alzheimer's disease
simufilam
Eisai bites back against restricted coverage plan for Aduhelm
Pharmaforum
Thu, 02/10/22 - 10:16 am
Eisai
Biogen
Aduhelm
Alzheimer's disease
FDA
CMS
Backing Biogen, 75+ House Republicans call on CMS to abandon its decision to limit amyloid-targeted Alzheimer's drugs to trials
Endpoints
Wed, 02/9/22 - 10:53 pm
Biogen
Aduhelm
CMS
Alzheimer's disease
'Very over sold': Biotech brags about PhII Alzheimer's data, but experts are underwhelmed
Endpoints
Wed, 02/9/22 - 10:11 am
Alzheon
Alzheimer's disease
ALZ-801
clinical trials
Biogen says U.S. FTC, SEC probing Alzheimer's disease drug
Reuters
Mon, 02/7/22 - 11:26 pm
Biogen
Aduhelm
FTC
SEC
Alzheimer's disease
Lilly slows FDA submission of Alzheimer's drug after Medicare decision
BioPharma Dive
Thu, 02/3/22 - 11:43 pm
Eli Lilly
donanemab
Alzheimer's disease
After disastrous start to launch, Biogen still expects 'minimal' sales from Aduhelm this year
Fierce Pharma
Thu, 02/3/22 - 11:45 am
Biogen
earnings
Aduhelm
Alzheimer's disease
A year of TIGIT (and Alzheimer’s) for Roche
EP Vantage
Thu, 02/3/22 - 10:53 am
Roche
Tigit
tiragolumab
Alzheimer's disease
CMS' Biogen decision could spell problems for Lilly, Roche Alzheimer's drugs, half of surveyed neurologists say
Fierce Pharma
Tue, 02/1/22 - 10:50 am
CMS
Biogen
Aduhelm
Eli Lilly
Roche
Alzheimer's disease
Lithium-Sparing Alzheimer’s Therapy has Strong Benefit-to-Risk Profile
BioSpace
Fri, 01/28/22 - 10:30 am
Alzamend Neuro
AL001
clinical trials
lithium
Alzheimer's disease
Cortexyme to shift focus after FDA places hold on experimental Alzheimer's drug
BioPharma Dive
Thu, 01/27/22 - 11:44 pm
Cortexyme
FDA
Alzheimer's disease
Under pressure, Biogen outlines ambitious diversity goals for Aduhelm study — but the Medicare fight is still on
Endpoints
Thu, 01/27/22 - 10:58 am
Biogen
Alzheimer's disease
clinical trials
clinical trial diversity
Aduhelm
A senior Biogen commercial exec exits Alzheimer's unit amid exodus as Aduhelm woes mount
Endpoints
Thu, 01/27/22 - 10:42 am
Biogen
Alzheimer's disease
Aduhelm
3 Clinical Trials to Watch in the First Half of 2022
Motley Fool
Sat, 01/22/22 - 02:20 pm
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Roche
Alzheimer's disease
gantenerumab
AbbVie
cystic fibrosis
Confidence is high for Eli Lilly CEO Ricks in showdown with Biogen's Aduhelm
Fierce Biotech
Fri, 01/21/22 - 11:13 am
Eli Lilly
Biogen
Alzheimer's disease
Aduhelm
donanemab
clinical trials
David Ricks
With its Aduhelm proposal, Medicare is stepping into a heated debate about how best to improve equity in Alzheimer’s treatment
Stat
Fri, 01/14/22 - 10:56 am
Medicare
Aduhelm
Biogen
CMS
racial disparity
Alzheimer's disease
Biogen leaders warn sales teams: Only 2,000 patients might access Aduhelm over the next several years
Endpoints
Thu, 01/13/22 - 10:26 pm
Biogen
Aduhelm
CMS
drug reps
Medicare
Alzheimer's disease

Pages